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1. Introduction 
Worldwide cervical cancer is the second most common malignancy in women with nearly a 
half million new cases diagnosed and 250,000 deaths each year Almost 80% of cases occur in 
low-income countries, where cervical cancer is the most common cancer in women (WHO, 
2009). In spite of recent advances in the development of new anticancer agents, cancer 
continues to be one of the major causes of death worldwide. Resistance to chemotherapeutic 
agents remains a principal obstacle in the successful treatment of cancer. Therefore, 
development and search of novel and effective anticancer agents to overcome resistance 
have become very important issues.  
As other cancers, radiotherapy and chemotherapy are the conventional cancer treatment 
used nowadays and remain the routine method for the treatment of cervical cancer. These 
approaches present sole limits related to the cost, problems of unstable efficiency and 
severe side effects whose reduce the quality of life and discourage patients to observe 
medication protocols which then lead to the progression of cancer and associated 
complications. In addition, many of these treatments present limited anti-cancer activities 
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(Mans, 2000). Therefore, development and search of novel and effective anticancer agents 
to overcome resistance and without severe side effects have become very important 
issues.  
During last decades, natural products have been an important source of chemotherapeutics, 
more than half of effective cancer drugs can be traced to natural origins (Ma, 2009). 
Approximately 60% of drugs currently used for cancer treatment have been isolated from 
natural products (Gordaliza, 2007; Newman, 2007). Currently, medicinal plants constitute a 
common alternative for cancer treatment in many countries around the world (Gerson-
Cwilich, 2006; Tascilar, 2006). 
Many candidate compounds that are able to arrest proliferation and induce apoptosis in 
neoplastic cells have been discovered. These include Vinca Alkaloids; Taxus diterpenes; 
Camptotheca Alkaloids; and Podophyllum lignans. Currently, there are 16 new plant-derived 
compounds being tested in clinical trials and of these 13 are being tested in phase I or II, and 
3 are in phase III. Among these compounds, flavopiridol, isolated from the Indian tree 
Dysoxylum binectariferum and mesoindigo, isolated from the Chinese plant Indigofera 
tinctoria, have been shown to exhibit anti-cancer effects with lesser toxicity than 
conventional drugs (Saklani A, 2008). 
In Morocco, medicinal plants have always been associated with cultural behaviour and 
traditional knowledge. Herbal remedies are frequently used to treat a large variety of 
ailments and symptoms, like a fever, inflammation, and pain (Gonzalez-Tejero, 2008). 
However, there is little information about their anti-cancer properties.  
Drug discovery from natural sources involves a multidisciplinary approach combining 
ethnobotanical, phytochemical and biological techniques to provide new chemical 
compounds for the development of new drugs against various pharmacological targets, 
including cancer and related complications. Cytotoxic screening models provide 
important preliminary data to select plant extracts with potential antineoplastic 
properties. The initial screenings are cell-based assays using established cell lines, in 
which the toxic effects of plant extracts or isolated compounds can be measured. Most of 
the clinically used antitumor agents possess significant cytotoxic activity in cell culture 
systems (Cardellina, 1999).  
In the course to contribute to development of new anticancer drugs against cervical 
cancer, the human cervical carcinoma SiHa and HeLa cell lines, has been used as a model 
system in this study for screening promising plant materials from folk Moroccan medicine 
possessing anticancer effect. Thus, seven medicinal plants: Inula viscosa L. (Ait.), Retama 
monosperma L. (Boiss.), Ormenis mixta L. (Dumont.), Ormenis eriolepis Coss., Rhamnus 
lycioides L., Berberis hispanica Bois. and Urginea maritima L. (Baker.) were collected and 
evaluated for the in vitro cytotoxic effect against SiHa and HeLa cell lines. The selection 
was made on the basis of their reputation as folk medicines and ethnobotanic 
informations to treat different illnesses and diseases. The selected plants have been 
described to exhibit several biological activities. However, the antiproliferative and 
apoptotic effects of these plants against cervical cancer cells have not yet been explored. 
The second part of this study, the most active plants were then selected and were 
evaluated for their potential antiproliferative effects against SiHa and HeLa cells. Furthers 
assays were used to elucidate its cytotoxic mechanism. 
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2. Materials and methods 
2.1 Plant species 
Seven plant species were collected from different regions of Morocco and were identified by 
Dr. M. Fennane from the Scientific Institute of Rabat. Voucher specimens are kept in the 
herbarium of institute. Table 1 shows the ethnobotanical data of the investigated plant 
species, including botanical names, local names, ethnomedical uses, as well as the plant 
parts employed in this study. 
 
Plants species 
(Family) 
Place of 
collection
Part plant 
collected
Traditional use pharmacological activities 
Inula viscosa L. Ait 
(Asteraceae) 
Ain atik 
Temara 
Leaves 
Skin diseases, treats 
cutaneous abcesses, wound 
healing, Tuberculosis, 
bronchial infections 
(Bellakhdar, 1997) 
Anti-inflammatory effects 
(Hernandez, 2007; Máñez, 
2007) 
 Antimicrobial activity 
(Maoz., 1998) 
Antifungal activity 
(Cafarchia, 2002) 
Retama 
monosperma 
L. Bois (Fabaceae) 
Sidi-
Boughaba 
Mahdia 
Leaves 
Purgative, vermifuge, 
antihelmintic, abortive and 
disinfectant (Benrahmoune, 
2003)
No information available 
Berberis hispanica 
Bois and Reut. 
(Berberidaceae) 
Tamahdit Bark roots 
Blood pressure, digestive, 
disorders, anorexia, urinary 
system, nephritic, liver and 
astrointestinal disorders, 
ocular affections, febrifuge, 
antileishmania, antitumoral 
(Bellakhdar, 1997)
Antimicrobial activity (Ai-
Rong, 2007) 
Antitumor activities 
(Fukuda, 1999; Meenakshi, 
2007) 
Ormenis eriolepis 
Coss. 
(Asteraceae) 
Ouarzazat Aerial part
Stomachic, anthelmintic 
and antidiabetic 
(Bellakhdar, 1997) 
Antibactrial activities (El 
Hanbali, 2004) 
Antileishmania activities (El 
Hanbali, 2005) 
Antifungic activity (Amani, 
2008)
Ormenis mixta 
(Asteraceae) 
Sidi-
Boughaba 
Mahdia
Aerial part
Drain the buttons, healing 
wounds (Haddad, 2003) 
Antimicrobial activity 
(Satrani, 2007) 
Rhamnus lycioides 
ssp. Oleoides 
(Rhamnaceae) 
Sidi-
Boughaba 
Mahdia
Leaves 
Laxative, diuretic and 
hepatic affections 
(Hmamouchi, 2001)
Hypotensive activity 
(Terencio, 1990) 
Urginea maritima 
L. Baker 
(Lemnaceae) 
Sidi-
Boughaba 
Mahdia 
Bulbs 
Cardiac failures, whooping-
cough, pneumonia, 
abortive, vipers bites, 
aphrodisiac, cough, 
bronchitis and the jaundice, 
diuretic and internal 
tumours (Bellakhdar, 1997)
Cytotoxic and antimalarial 
activities (Sathiyamoorthy, 
1999) 
Table 1. Ethnobotanical data and some reported pharmacological activities of plants species 
used in this study. 
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2.2 Plant extracts preparation 
The seven Plants were dried and ground finely. 20g of each powdered plant were extracted 
by absolute methanol (100 ml, three times) for 72 h at room temperature. The extracts were 
evaporated to dryness under reduced pressure at 40°C. A total of 40 mg of obtained extract 
were dissolved in dimethyl sulfoxide (DMSO) to give a solution stock to 40 mg/ml and 
conserved at -20°C until use.  
In second part of the study, the most actives plants were submitted to extraction with 
solvents with different polarities. Inula viscosa L. and Retama monosperma L. were extracted 
successively in a Soxhlet with n-hexane and methanol. The resulting extracts were then 
evaporated by Rotavapor to give dried extracts. The methanol concentrated extract was 
dissolved in distilled water and was successively extracted with dichloromethane and ethyl 
acetate. The solvent was evaporated to obtain the crudes extracts, and kept in the dark at +4 °C 
until tested. 
2.3 Cell lines 
Human cervical cancer SiHa and HeLa cell lines were used in this study. Cells were grown 
as monolayers in Minimum Essential Medium (MEM) supplemented with 10% heat-
inactivated fetal calf serum and 1% Penicillin-Spreptomycin mixture. Cultures were 
maintained at 37°C in 5% CO2. SiHa and HeLa cell lines were kindly provided by Dr. P. 
Coursaget, INSERM U618, University François Rabelais, Tours, France. 
2.4 Cytotoxicity assay 
Cytotoxicity of the plant extracts was determined using the MTT Assay as described 
previously (Mosmann, 1983). Cells were seeded in 96-well microplates. After 24 h of culture, 
the cells were treated with different concentrations ranging from 15.6 to 500 μg/ml, in 
quadruplicate for 48h or 72h incubation. 10μL MTT (5mg/mL) was added to each well. 
After 4 hours incubation, 150μL DMSO were added to dissolve purple formazan crystals, 
and absorbance was then determined using a spectrophotometer at 590nm. Mitomycin C 
and vinblastin (~ 95 % HPLC, sigma-Aldrich) were used as a positive control. 
2.5 Detection of the morphological changes associated with apoptosis 
SiHa and HeLa cells were cultured on glass chamber slides in 2 well plates and were treated 
with the IV-HE, IV-DF and Rm-DF for 24h , 48h and 72h at a concentration of 20µg/ml. 
After incubation, cells were washed with PBS twice and fixed with (4% paraformaldehyde 
and 0.1% Triton X-100) for 5 min. The cells were then washed with PBS and incubated with 
Hoecsht 33342 (10µg/ml) (Sigma) at 37 °C for 30min. The cells were visualized through 
fluorescence inverted microscope (Axiovert 200M Zeiss, Germany) equipped with an LD 
achroplan 40X objective. The images were collected with a CCD cooled camera (Coolsnap 
HQ, Ropper Scientific). 
2.6 Mitochondrial membrane potential (∆Ψm ) measurement 
Analysis of mitochondrial membrane potential was carried out using the lipophilic cationic 
probe, JC-1 (Molecular Probes, Eugene, OR) whose monomer emits at 530 nm (green) after 
www.intechopen.com
Antiproliferative Effect and Induction of Apoptosis by  
Inula viscosa L. and Retama monosperma L. Extracts in Human Cervical Cancer Cells 
 
271 
excitation at 500 nm. Depending on the mitochondrial membrane potential, JC-1 is able to 
form J-aggregates respectively from green to yellow-orange fluorescence emission (590 nm) 
as mitochondrial membrane becomes more polarized. Therefore, the I590nm/I530nm emission 
ratio value allows observation of mitochondrial dysfunction. SiHa and HeLa cells were 
treated with the extract for 24 h or 48h. JC-1 reagent (10µM) was added for 20 min at 37 °C in 
the dark. Cells were then washed with PBS and centrifuged at 1500 rpm, 4°C for 5 min. The 
pellet was resuspended in 1 ml ice-cold PBS and the measurements were performed using 
the Spectrofluorometer (RF-5301PC, Shimadzu, Tokyo, Japan). Residual mitochondrial 
potential as percentage of control was expressed as follows: (R treated/R control) x 100; R = 
I590 nm/I530 nm.  
2.7 Reactive oxygene species (ROS) production 
Production of ROS (reactive oxygen species) was monitored via oxidation of the 
carboxydichlorofluorescein analog probe, C2938. SiHa and HeLa cells (2 x105) were seeded 
into a 6-well plate and treated with the appropriate concentration of the extract for 24 h. 
Control and treated cells were washed and stained with 10 µM C2938 (30 min, 37˚C). 
Fluorescence emission from the oxidized probe was quantified with a 
Spectrofluorophotometer (RF-5301PC, Shimadzu) (excitation: 488±1 nm; emission: 518±1 
nm). 
2.8 Western blot analysis 
Cells were treated with 20 µg/ml of extracts for (24h, 48h and 72h), scrapped, washed with 
PBS and lysed in ice-cold lysis buffer (10 mM Tris pH 7.4, 150 mM NaCl, 5 mM EDTA, 1 mM 
Na3VO4, 1mM dithiothreitol, 10µg/ml Leupeptin , 10µg/ml aprotinin, 10% glycerol, 1%Brij 
(v/v)) , placed on ice for 20 and centrifuged at 14,000g for 15 min at 4 °C. The amount of 
protein was determined using the Bio-Rad protein quantification kit. Equal amounts of 
proteins (25-30µg/ml) was subjected to electrophorese on SDS-polyacrylamide gels and, 
transferred to a Nitrocellulose membrane by electroblotting. After blocking non-specific 
sites, the membrane was incubated overnight with appropriate primary antibodies: 
Monoclonal anti- pro-Caspase 3 (1/700), Monoclonal anti-ǃ actin (dilution 1/5000), 
Monoclonal anti-BCl2 (1/700) and polyclonal anti- PARP (1/1000). Horseradish peroxidase-
conjugated goat anti-rabbit or anti-mouse IgG were used as secondary antibodies and 
proteins were detected using an enhanced chemiluminescence (ECL) kit.  
2.9 Gas chromatography/mass spectrometry (GC/MS) analysis 
The identification of the compounds from I. viscosa hexanic fraction (IV-HE) and R. 
monosperma dichloromethane fraction (Rm-DF) was performed by (GC/MS) analysis using a 
Hewlett Packard 5890 II Gaz Chromatograph, equipped with a HP 5972 Mass selective 
detector and a VB5 ( 5% phenyl ; 95% methylpolisyloxane) capillary column (30 m, 0.25 mm, 
film thickness 0.25 µm). Injection volume was 1 µl with a splitless; the injector and detector 
temperatures was held constant at 250. For GC/MS detection an electron ionization system 
with ionization energy of 70 eV was used. Helium was used as the carrier gas with an inlet 
pressure of 10.48 psi, corresponding to a flow rate of 1.0 ml/min. The analytical conditions 
worked the following programme: oven temperature from 60 to 280°C at rate of 16°C min -1, 
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the final temperature of 300°C was held for 10 min. Tentative identification of the 
compounds was based on the comparison of their relative retention time and spectral mass 
with those of Nist and Wiley7 library data of the GC/MS system.  
2.10 Statistical analysis 
Data are presented as means ± SD of at least triplicate or quadruplicate determinations of 
three different assays. The statistical analysis was performed by student’s-test with 
Microsoft excel software. Significant differences are indicated by *p < 0.05; **p < 0.01; ***p < 
0.001. 
3. Results and discussion 
3.1 Cytotoxic effect of the medicinal plants extracts from Morocco 
Crude extracts of selected plants were made by exhaustive methanol extraction. These 
plants extracts were tested for their potential cytotoxic effects, SiHa and HeLa cells were 
treated with plants extracts at different concentrations ranging from 15 to 500 μg/ml for 48h. 
The cells viability were determined by MTT assay. Among the 7 medicinal plant extracts, 
methanolic extract from Inula viscosa L. and Retama monosperma L. have been found to 
exhibit marked cytotoxic effect on both SiHa and HeLa cell lines. Their IC50 values were 
54±12 and 99±1 µg/ml in SiHa cells and 60±8 and 112±4 µg/ml in HeLa cells, respectively. 
The methanolic extract of Ormenis eriolepis Coss., Ormenis mixta L. and Berberis hispanica 
Boiss. have lower cytotoxic effect on the cancer cell lines tested (Table 2). However, Urginea 
maritime L. and Rhamnus lycioides L. had insignificant or no cytotoxic effects at tested 
concentration with IC50 互500µ/ml. 
 
Methanolic extracts 
IC50 ± SD (μg/ml) 
SiHa HeLa 
Inula viscosa L. 54 ± 12 60 ± 8 
Ormenis eriolepis Coss. 94 ± 4 112 ± 4 
Ormenis mixta L. 383 ± 26 311± 14 
Berberis hispanica Boiss. 178 ± 5 224 ± 10 
Retama Monosperma L. 99 ± 1 96 ± 4 
Urginea maritime L. › 500 › 500 
Rhamnus lycioides L. › 500 › 500 
Mitomycin C 6 ± 1 1 ± 0.30 
Table 2. Cytotoxic activity of methanolic extracts of some medicinal plants from Morocco on 
SiHa and HeLa cervical cancer cell lines. 
Inula viscosa L. (Ait.) and Retama monosperma L. methanolic extracts showed the highest 
cytotoxic activity with lowest IC50 values. Previous studies have reported interesting 
biological activities with potential therapeutic applications of these plants. Inula viscosa L. is 
used in Moroccan folk medicine as antihelmintic, diuretic, anemia and as cataplasm for 
rheumatic pain (Hmamouchi, 2001), tuberculosis, expectorant and treatment of bronchitis 
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(Bellakhdar, 1997). The aerial part of this plant is used as decoction in the treatment of 
diabetes, hypertension and renal diseases (Eddouks, 2002). This plant has been described to 
exhibit several biological activities such as anti-inflammatory (Hernández, 2007), 
antimicrobial (Maoz, 1998) and antifungal effects (Cafarchia, 2002). Retama monosperma L. is 
used in the traditional medicine of many countries, as a purgative, vermifuge, antihelmintic 
and abortive (Bellakhdar, 1997). Moreover, it has been reported that Retama Genus for a 
various pharmacological effects, including an hypoglycemic and diuretic (Maghrani, 2005a; 
Maghrani, 2005b), cytotoxic (Conforti, 2004; Hayet, 2007; López-Lázaro, 2000), antioxidant 
and antiviral (Edziri, 2010) and antihypertensive (Eddouks, 2007). 
Cells were exposed to different concentrations of extracts for 48h. Data are expressed as IC50 
values (µg/ml) and are means ± SD of three experiments. Mitomycine was used as positive 
control.  
The cytotoxic effect of extracts from Inula viscosa L. and Retama monosperma L. 
As evidenced by MTT assays, we found that hexanic (IV-HE) and dichloromethane (IV-DF) 
extracts from Inula viscosa were able to inhibit cell growth in dose-dependent manner after 
72h of treatment, in both cell lines. The IC50 values for IV-HE on SiHa and HeLa were 
9.56±1.68 and 13.17±0.79 μg/ml, respectively. However, for IV-DF, the IC50 values on SiHa 
and HeLa were respectively 6.54±1.46 and 22.04±3.31 μg/ml. Retama monosperma 
dichloromethane fraction (Rm-DF) was the most active extract, exhibiting also cytotoxic 
activity against both cells lines in dose-dependent manner. Values of IC50 obtained were 14± 
and 21±µg/ml, in SiHa and HeLa cell lines respectively (Table 3). The American National 
Cancer Institute assigns a significant cytotoxic effect of promising anticancer product for 
future bio-guided studies if it exerts an IC50 value 五30 μg/ml (Suffnes, 1990). The obtained 
results indicate that IV-HE and IV-DF and Rm-DF were shown to induce significant and 
dose-dependent inhibitory activities against human cervical cancer cell lines SiHa and HeLa. 
 
Extracts 
IC50 (µg/ml) 
SiHa HeLa 
Retama monosperma L. extracts   
Hexane extract (Rm-HE) › 80 › 80 
Methanol extract (Rm-ME) › 80 › 80 
Dichloromethane fraction (Rm-DF) 14.57±4.15 21.33±7.88 
Acetate ethyle fraction (Rm-AF) 27.54±5.64 77.47±2.25 
Inula viscosa L. extracts   
Hexane extract (IV-HE) 9.56 ± 1.68  13.17±0.79 
Methanol extract (IV-ME) 52.83±3.28  › 80 
Dichloromethane fraction (IV-DF) 6.54±1.46  22.04±3.31 
Ethyl acetate fraction (IV-AF) 63.62±10.55  › 80 
Vinblastin 10.88±0.78  6.28±0,35 
Table 3. Cytotoxic effect of extracts and fractions of Retama monosperma L. and Inula viscosa L. 
extracts against SiHa and HeLa cervical cancer cells.  
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Cells were exposed to different concentrations of extracts for 72h. As determined by MTT 
assay. Data are expressed as IC50 values (µg/ml) and are means ± SD of three experiments. 
Vinblastin was used as a positive control.  
3.2 Chemical identification of plants extracts 
Analyses of the most active extracts by gas chromatography (GC) coupled with and GC-
mass spectrometry (MS) revealed the presence of a sesquiterpene acid: isocostic acid 
(46.05%) and two sesquiterpenes lactones: tomentosin (33.27%) and inuviscolide (13.04%), as 
major compounds in IV-HE extract (Table 4). In the fact, Inula viscosa L. is source of a 
number of bioactives compounds as well as flavonoids (Hernandez, 2007) and sesquiterpene 
derivatives (Fontana, 2007).  
 
Extracts Compounds RT Area (%) 
IV-HE 
1-Amino-1-ortho-chlorophenyl-2-(2-quinoxalinyl)ethene 12.79 0.21 
3-(4'-Methoxyphenyl)-1-acetyl-2-phenylindolizine 24.99 1.68 
Isocostic acid 40.56 46.05 
Isoaromadendrene epoxide 41.38 1.44 
Phenanthrene, 7-ethenyl-1,2,3,4,4ǂ,4ǃ,5,6,7,8,10,10ǂ- 
dodecahydro-4ǂ,7-dimethyl-1-methylene-, [4ǂS-
(4ǂǂ',4ǃǂ',7ǂ',10ǂǂ')]- 
42.74 0.69 
Iso-velleral 46.26 1.87 
6,9,12,15-Docosatetraenoic acid, methyl ester 46.82 0.37 
Quercetin 7,3',4'-trimethoxy 46.93 0.22 
Tomentosin 47.27 33.27 
Inuviscolide 47.39 13.04 
Tetracosane  54.32 0.77 
6-Imino-8-(3',5'-dichlorolphenyl)-3,4-dihydro-2H, 6H-
pyrimido[2,1-ǃ][1,3]thiazine-7-carbonitrile 57.78 0.39 
IV-DF 
Benzeneacetic acid, ǂ',4-bis[(trimethylsilyl)oxy]-, trimethylsilyl 
ester  
18 .91 10.44 
9H-pyrrolo[3',4':3,4]pyrrolo[2,1-a]phthalazine-9,11(10H)-
dione,10-ethyl-8-phenyl 
24.99 47.85 
Isocostic acid 40.56 2.29 
1 ,2-longidione 44.54 5.03 
10 hydroxy-1 ,4,5,8-Tetramethyl anthrone 44.84 2.54 
Chiapin B 46.27 1.55 
2,4,7 Trimethyl-5 ,6-diphenyl-1H-isoindol-1 ,3(2H)-dione 47.01 9.12 
Tomentosin 47.26 13.93 
Methyl 2,3-Dideoxy-4-O-propargyl-6-O-(tert-butyldimethylsilyl)-
ǂ-D-erythro-hex-2-enopyranoside 55.92 7.24 
Area (%):(%): area percentage (peak area relative to the total peak area percentage). 
RT : Retention time (min).  
Table 4. Compounds present within Inula viscosa L. extracts identified by CG/MS. 
www.intechopen.com
Antiproliferative Effect and Induction of Apoptosis by  
Inula viscosa L. and Retama monosperma L. Extracts in Human Cervical Cancer Cells 
 
275 
However, CG/MS analysis of Rm-DF (Table 5) revealed the presence of five known 
quinolizidine alkaloids as well as, sparteine (10.97%), L- methyl cytisine (9.11%), 17-
oxosparteine (3.49%), lupanine (0.93%) and anagyrine (39.63%). The Retama species have 
been reported to contain alkaloids (Abdel Halim, 1997) and flavonoids (Kassem, 2000). 
Fifteen quinolizidine and 3 dipiperidine alkaloids were isolated from the leaves of flowering 
plants of R. monosperma collected from Morocco (Touati, 1996). 
 
Extracts Compounds RT Area(%) 
Rm-DF 
ǂ-Pinene 9,89 2.73 
1,8-Cineole 13,79 8.03 
Benzeneacetic acid, ǂ,4-bis[(trimethylsilyl)oxy]-, 18.91 4.71 
trimethylsilyl ester  
9H-pyrrolo[3',4':3,4]pyrrolo[2,1-a]phthalazine-9, 24.99 19.05 
11(10H)-dione,10-ethyl-8-phenyl  
Sparteine 38,98 10.97 
Hexadecanoic acid 42,71 0.86 
L methyl cytisine 44,23 9.11 
17- oxosparteine 46,67 3.49 
4-(N-(3-trifluoromethylphenyl)-amino)-5,6-dimethyl-
7H-pyrro[2.3-d]pyrimidine 
47.78 0.50 
Lupanine 48,78 0.93 
Anagyrine 53 ,73 39.63 
Area (%):(%): area percentage (peak area relative to the total peak area percentage). 
RT : Retention time (min). 
Table 5. Compounds present within R. monosperma L. extracts identified by CG/MS. 
3.3 Molecular mechanisms of apoptosis signalling pathways 
Induction of apoptosis constitute an important mechanism for anticancer effects of many 
naturally occurring and synthetic agents. Activation of apoptotic pathways seems to be an 
effective strategy against tumor progression (Brown, 2005). The caspase pathway plays a 
pivotal role in the induction, transduction and amplification of intracellular apoptotic 
signals. Among the caspase family proteins, capase-3 is responsible for the proteolytic 
cleavage of many key proteins such as PARP, which is considered as a marker of apoptosis 
(Kothakota, 1997; Wang, 2005).  
3.4 IV-HE, IV-DF and Rm-DF induced apoptosis in SiHa and HeLa cells 
In order to determine whether plant extracts induced cell death was due to apoptosis, we 
analyzed chromatin condensation and nuclear fragmentation by Hoechst 33342 staining and 
fluorescence microscopy (Kerr, 1994). SiHa and HeLa cells were treated with IV-HE, IV-DF 
and Rm-DF for 24h, 48h and 72h. As shown in Figure 1, the rate of apoptotic cells was 
increased significantly in a time-dependant manner after treatment with IV-HE, IV-DF and 
Rm-DF (Figure.1). 
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Fig. 1. IV-HE, IV-DF and Rm-DF induce apoptosis of cervical cancer cells. SiHa (A) and 
HeLa (B) cells were treated IV-HE, IV-DF and Rm-DF and stained with Hoechst 33342. 
Condensed, fragmented nuclei and apoptotic bodies were seen in the treated cells. The 
stained nuclei were visualized and photographed with an inverted fluorescence microscope 
(Axiovert 200M Zeiss). Data represent at least two experiments (Magnification: x 400). 
3.5 Expression of Pro-caspase, Bcl2 and PARP cleavage 
Inula viscosa and Retama monosperma extracts were able to induce apoptosis in HeLa and 
SiHa cells as evidenced by western blot analysis. Activation of caspase-3 causes 
the cleavage of poly-(ADP-ribose)-polymerase (PARP), a hallmark of apoptosis, to produce 
an 85 kDa fragment during apoptosis (Tewari, 1995). After treatment of cells, a procaspase-3 
cleavage and cleavage of poly (ADP-ribose) polymerase (PARP) were observed in time- and 
dose-dependent manner. IV-HE, IV-DF and Rm-DF caused the proteolytic cleavage of PARP 
with accumulation of the 85 kDa fragment in SiHa and HeLa cells (Figure 2.A; 2.B). This  
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Fig. 2. Expression of Pro-caspase 3 , Bcl-2 and PARP proteins in HeLa and SiHa treated-cells 
analysed by Western blot. After treatment with 20µg/ml of IV-HE, IV-DF (A) and Rm-DF 
(B) during 24h and 48 h or 72h, cell lysates were prepared and the proteins were separated 
on SDS-polyacrylamide gel and transferred into nitrocellulose membranes. The membranes 
were probed with the indicated antibodies. ǃ-actin was used as a control for protein loading. 
The results shown here were from two or three representative experiments. 
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suggests that apoptosis induced by IV-HE, IV-DF and Rm-DF could be associated with a 
caspase-dependent pathway.  
The activation and function of caspases are regulated by various key of molecules, such as 
inhibitors of apoptosis protein, Bcl-2 protein family. Increased expression of the anti-
apoptotic protein Bcl-2 causes resistance to chemotherapeutic drugs, while decreasing Bcl-2 
expression may promote apoptotic responses to anticancer drugs (Reed J.C., 1994). Our 
investigations showed a significant decrease in Bcl-2 expression after 24h treatment with IV-
HE, IV-DF and Rm-DF (Figure 2A, 2B).  
3.6 Statut of mitochondrial membrane potential 
Mitochondrial dysfunction has been shown to participate in the induction of apoptosis. 
Indeed, opening of the mitochondrial permeability transition pore has been demonstrated to 
induce depolarization of the transmembrane potential (ΔΨm), release of apoptogenic factors 
and loss of oxidative phosphorylation (Zimmermann, 2001). To characterize the effect of IV-
HE, IV-DF and Rm-DF on the mitochondrial apoptotic pathway, we measured the 
mitochondrial membrane potential (∆Ψm) in SiHa and HeLa cells after treatment for 24h. As 
shown in (Figure.3), IV-HE, IV-DF and Rm-DF, induced a significant decrease in 
mitochondrial membrane potential (ΔΨm), in both SiHa and HeLa cells.  
 
 
 
Fig. 3. Mitochondrial membrane potential state in treated cells with IV-HE, IV-DF and Rm-
DF, measured by spectrofluorometry and JC-1 probe in SiHa (A) and HeLa (B). Cells are 
treated with 20µg/ml of extracts for 24h as described in Materials and Methods. The results 
are presented as the mean ± SD of three independent experiments. 
3.7 Measurement of ROS production 
Mitochondria are a source of ROS during apoptosis and reduced mitochondria membrane 
potential leads to increased generation of ROS and apoptosis (Zamzami, 1995). We 
investigate whether the intracellular ROS are involved in the signal transduction 
pathways of apoptosis. ROS generation was measured after cells treatment with IV-HE, 
IV-DF and Rm-DF (20µg/ml) for 24h, using a ROS-sensitive fluorescent C2938 probe. 
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Tested extracts showed a dose-dependent increase in the intracellular ROS production 
when compared to the control (Figure.4). This indicate that ROS generation induced by 
IV-HE, IV-DF and Rm-DF in SiHa and HeLa cells can contribute to apoptosis via the 
mitochondrial pathway. 
 
 
 
 
Fig. 4. ROS production in treated cells with IV-HE, IV-DF and Rm-DF, using an oxydation-
sensitive fluorescent C2938 probe in SiHa (A) and HeLa (B). Cells are treated with 20µg/ml 
of extracts for 24h as described in Materials and Methods. The results are presented as the 
mean ± SD of three independent experiments. 
Taken together, these results show clearly that the hexanic extract of Inula viscosa and 
dichloromethane fractions of both Inula viscosa and Retama monosperma have cytotoxic effects 
against cervical cancer cell lines SiHa and Hela by inducing apoptotic process. Previous 
studies have showed that some plant extracts with pronounced cytotoxic in vitro had 
marked effects in vivo and showed promising potential to be used as an anticancer drugs. 
Indeed, sesquiterpene lactones, isolated from Carpesium rosulatum, have recently been 
largely studied for their pharmacological proprieties as anti-neoplastic agents (Ma G, 2009; 
Moon, 2011; Robinson, 2008; Taylor, 2008). Sesquiterpenes lactones, artemisinin, 
thapsigargin and parthenolide and many of their synthetic derivatives, are in advanced 
stage for clinical trials (Ghantous, 2010). 
Phytochemicals contained in Inula viscosa L. extracts including like tomentosin and 
inuviscolide, as evidenced by CG/MS analysis, have been shown recently to possess an 
antiproliferative and apoptotic effects on human melanoma cell lines (Rozenblat, 2008).  
Quinolizidine alkaloids are known to present in Retama monosperma as main active 
constituents. Quinolizidine alkaloids contained in the dichloromethane fraction of Retama 
monosperma L. extract, may act as potential in vitro cytotoxic agents against human 
cervical cancer cells through the induction of apoptosis. In fact, previous reports have 
shown that quinolizidine alkaloids have been found to elicit a range of biological activities, 
including antiviral (Ding, 2006), antihypoglycemic (Brukwicki, 2009) and anti-tumoral 
(Zhang, 2010) activities. 
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4. Conclusion 
The hexanic extract of Inula viscosa and dichloromethane fractions of both Inula viscosa and 
Retama monosperma showed pronounced cytotoxic effects against cervical cancer cell lines 
through the inhibition of proliferation and induction of apoptosis caspase-dependent and 
involving a mitochondria-mediated signaling pathway. Our findings suggest that these 
extracts might provide compounds which could be potential sources of anticancer drug 
leads. Further investigation into the isolation, characterization and mechanism of cytotoxic 
compounds from the selected plants extracts and in vivo are necessary. Moreover it will be 
interesting to use some in vivo models to evaluate the anti-tumor activity of these plant 
extracts.  
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